Ginkgo Bioworks Holdings, Inc. shares fall 1.60% in premarket as overall U.S. stock market rises.

Ginkgo Bioworks Holdings, Inc. surged 19.20% in premarket trading, driven by a broader market rally with the Dow Jones Industrial Average rising over 100 points. The company specializes in a cell programming platform, offering end-to-end cell engineering and biosafety services across pharmaceuticals, agriculture, and industrial sectors, supporting high-demand markets such as drug development and antibody research.